MAPT and Alzheimer disease: These miRNAs participate in the pathogenesis of AD by regulating and influencing key molecules such as microtubule-associated protein tau, amyloid precursor protein (APP), and β-site APP-cleaving enzyme 1 (BACE1) (Wang et al., 2023).